메뉴 건너뛰기




Volumn 9, Issue SUPPL. 2, 2002, Pages

MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE ALBUMIN; PROTEIN TYROSINE KINASE INHIBITOR; SHU 555C; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; VATALANIB; ANGIOGENESIS INHIBITOR; DIAGNOSTIC AGENT; ENDOTHELIAL CELL GROWTH FACTOR; GADOLINIUM PENTETATE; IRON; LYMPHOKINE; OXIDE; PHTHALAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

EID: 0036333725     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)80281-7     Document Type: Conference Paper
Times cited : (18)

References (2)
  • 1
    • 0034655182 scopus 로고    scopus 로고
    • PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration
    • (2000) Cancer Res , vol.60 , pp. 2178-2189
    • Wood, J.M.1    Bold, G.2    Buchdunger, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.